I. In vitro model: MIAPaCa2 (NQO1+) pancreatic cancer cells (sensitive to β-lapachone)II. Treatment groups: (i) β-lapachone, (ii) no treatment. This evidence concerns the gene NQO1 and pancreatic neoplasm.